Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fey

Showing results (211-220 of 271) with videos related to

Pageof 28
Sort By:
Oncogene|May 23, 2006
Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophilsS Martinelli, G Kostylina, V Niggli, et al.
British Journal of Haematology|May 27, 2009
SIRT1 is downregulated during neutrophil differentiation of acute promyelocytic leukaemia cellsJulian Wampfler, Mario P Tschan, Deborah Shan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?J Bernhard, B Thürlimann, S F Schmitz, et al.
British Journal of Haematology|March 6, 2008
HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiationChristian Britschgi, Mathias Jenal, Mattia Rizzi, et al.
Blood|February 15, 1994
Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probeM F Fey, S Liechti-Gallati, A von Rohr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemiasD C Betticher, M F Fey, A von Rohr, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK)J Bernhard, M Castiglione-Gertsch, S F Schmitz, et al.
British Journal of Haematology|December 21, 2012
The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patientsElena A Federzoni, Magali Humbert, Peter J M Valk, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|December 26, 2001
Expression of TCL1 in hematologic disordersJ Roos, I Hennig, J Schwaller, et al.
Leukemia & Lymphoma|November 8, 2001
Different p16INK4a and p14ARF expression patterns in acute myeloid leukaemia and normal blood leukocytesM P Tschan, S Vonlanthen, J F Cajot, et al.
Pageof 28

Showing results (211-220 of 271) with videos related to

Sort By:
Pageof 28
Oncogene|May 23, 2006
Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophilsS Martinelli, G Kostylina, V Niggli, et al.
British Journal of Haematology|May 27, 2009
SIRT1 is downregulated during neutrophil differentiation of acute promyelocytic leukaemia cellsJulian Wampfler, Mario P Tschan, Deborah Shan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?J Bernhard, B Thürlimann, S F Schmitz, et al.
British Journal of Haematology|March 6, 2008
HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiationChristian Britschgi, Mathias Jenal, Mattia Rizzi, et al.
Blood|February 15, 1994
Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probeM F Fey, S Liechti-Gallati, A von Rohr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemiasD C Betticher, M F Fey, A von Rohr, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK)J Bernhard, M Castiglione-Gertsch, S F Schmitz, et al.
British Journal of Haematology|December 21, 2012
The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patientsElena A Federzoni, Magali Humbert, Peter J M Valk, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|December 26, 2001
Expression of TCL1 in hematologic disordersJ Roos, I Hennig, J Schwaller, et al.
Leukemia & Lymphoma|November 8, 2001
Different p16INK4a and p14ARF expression patterns in acute myeloid leukaemia and normal blood leukocytesM P Tschan, S Vonlanthen, J F Cajot, et al.
Pageof 28